Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P50
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | -3.52% |
| 2024 | -24.81% |
| 2023 | -244.55% |
| 2022 | 47.34% |
| 2021 | -249.38% |
| 2020 | 20.41% |
| 2019 | 0.00% |